China Shineway Pharmaceutical Group Limited (HKG:2877)
8.70
-0.05 (-0.57%)
Mar 12, 2025, 4:08 PM HKT
HKG:2877 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 11, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 6,610 | 5,492 | 5,733 | 5,205 | 4,007 | 5,708 | Upgrade
|
Market Cap Growth | -12.91% | -4.22% | 10.16% | 29.89% | -29.80% | -8.18% | Upgrade
|
Enterprise Value | 287 | 24 | 537 | 224 | 200 | 1,681 | Upgrade
|
Last Close Price | 8.75 | 6.82 | 6.72 | 5.73 | 4.05 | 5.25 | Upgrade
|
PE Ratio | 5.58 | 5.14 | 7.02 | 7.62 | 11.44 | 10.14 | Upgrade
|
Forward PE | 6.42 | 5.10 | 7.57 | 6.45 | 6.41 | 8.56 | Upgrade
|
PS Ratio | 1.46 | 1.10 | 1.28 | 1.32 | 1.27 | 1.89 | Upgrade
|
PB Ratio | 0.84 | 0.71 | 0.79 | 0.72 | 0.58 | 0.88 | Upgrade
|
P/TBV Ratio | 0.76 | 0.73 | 0.82 | 0.75 | 0.60 | 0.95 | Upgrade
|
P/FCF Ratio | 6.12 | 6.32 | 5.17 | 6.96 | 5.89 | 18.25 | Upgrade
|
P/OCF Ratio | 4.60 | 5.34 | 4.57 | 6.03 | 5.28 | 13.87 | Upgrade
|
PEG Ratio | 0.76 | 1.36 | 1.36 | 1.36 | 1.28 | 0.47 | Upgrade
|
EV/Sales Ratio | 0.06 | 0.00 | 0.12 | 0.06 | 0.06 | 0.56 | Upgrade
|
EV/EBITDA Ratio | 0.24 | 0.02 | 0.53 | 0.26 | 0.27 | 2.23 | Upgrade
|
EV/EBIT Ratio | 0.28 | 0.02 | 0.67 | 0.34 | 0.40 | 3.15 | Upgrade
|
EV/FCF Ratio | 0.27 | 0.03 | 0.48 | 0.30 | 0.29 | 5.37 | Upgrade
|
Debt / Equity Ratio | 0.05 | 0.04 | 0.00 | 0.00 | 0.07 | 0.07 | Upgrade
|
Debt / EBITDA Ratio | 0.31 | 0.26 | 0.01 | 0.02 | 0.62 | 0.59 | Upgrade
|
Debt / FCF Ratio | 0.35 | 0.38 | 0.01 | 0.02 | 0.68 | 1.45 | Upgrade
|
Asset Turnover | 0.45 | 0.51 | 0.51 | 0.45 | 0.37 | 0.39 | Upgrade
|
Inventory Turnover | 1.28 | 1.44 | 1.63 | 1.58 | 1.53 | 1.73 | Upgrade
|
Quick Ratio | 3.09 | 2.97 | 3.66 | 4.62 | 3.96 | 3.96 | Upgrade
|
Current Ratio | 3.48 | 3.35 | 4.07 | 5.19 | 4.62 | 4.42 | Upgrade
|
Return on Equity (ROE) | 15.81% | 14.45% | 11.77% | 9.52% | 5.10% | 8.72% | Upgrade
|
Return on Assets (ROA) | 6.29% | 6.81% | 5.78% | 4.63% | 3.68% | 4.30% | Upgrade
|
Return on Capital (ROIC) | 8.07% | 8.83% | 7.25% | 5.52% | 4.27% | 4.99% | Upgrade
|
Return on Capital Employed (ROCE) | 12.68% | 13.59% | 10.87% | 8.75% | 7.02% | 8.00% | Upgrade
|
Earnings Yield | 17.96% | 19.45% | 14.25% | 13.13% | 8.74% | 9.86% | Upgrade
|
FCF Yield | 16.35% | 15.81% | 19.33% | 14.37% | 16.97% | 5.48% | Upgrade
|
Dividend Yield | 6.64% | 6.78% | 5.38% | 8.36% | 9.39% | 4.91% | Upgrade
|
Payout Ratio | 36.93% | 32.72% | 33.44% | 81.39% | 58.83% | 35.53% | Upgrade
|
Buyback Yield / Dilution | - | -0.03% | 0.21% | 3.10% | 4.51% | Upgrade
| |
Total Shareholder Return | 6.64% | 6.78% | 5.35% | 8.57% | 12.48% | 9.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.